P.115 Membrane lipids in early phases of psychosis: potential biomarkers for a personalised medicine?
Saved in:
| Published in: | European neuropsychopharmacology Vol. 44; pp. S11 - S12 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Elsevier B.V
01-03-2021
|
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Author | Nuss, P. Krebs, M.O. Chaumette, B. Lamazière, A. Tessier, C. Kebir, O. Frajerman, A. |
|---|---|
| Author_xml | – sequence: 1 givenname: A. surname: Frajerman fullname: Frajerman, A. organization: Institut de Psychiatrie et Neurosciences de Paris IPNP- UMR_S1266- INSERM- Université de Paris, Institut de Psychiatrie et Neurosciences de Paris, Paris, France – sequence: 2 givenname: B. surname: Chaumette fullname: Chaumette, B. organization: Institut de Psychiatrie et Neurosciences de Paris IPNP- UMR_S1266- INSERM- Université de Paris, Institut de Psychiatrie et Neurosciences de Paris, Paris, France – sequence: 3 givenname: A. surname: Lamazière fullname: Lamazière, A. organization: Inserm UMR S 938- département METOMICS- centre de recherche Saint-Antoine- Sorbonne Université- AP–HP- Paris- France, centre de recherche Saint-Antoine, paris, France – sequence: 4 givenname: C. surname: Tessier fullname: Tessier, C. organization: ERL 1157- laboratoire de spectrométrie de masse- CHU de Saint-Antoine- Paris- France, CHU de Saint-Antoine, Paris, France – sequence: 5 givenname: P. surname: Nuss fullname: Nuss, P. organization: Inserm UMR S 938- département METOMICS- centre de recherche Saint-Antoine- Sorbonne Université- AP–HP- Paris- France, centre de recherche Saint-Antoine, paris, France – sequence: 6 givenname: M.O. surname: Krebs fullname: Krebs, M.O. organization: Institut de Psychiatrie et Neurosciences de Paris IPNP- UMR_S1266- INSERM- Université de Paris, Institut de Psychiatrie et Neurosciences de Paris, Paris, France – sequence: 7 givenname: O. surname: Kebir fullname: Kebir, O. organization: Institut de Psychiatrie et Neurosciences de Paris IPNP- UMR_S1266- INSERM- Université de Paris, Institut de Psychiatrie et Neurosciences de Paris, Paris, France |
| BookMark | eNqFUF1LAzEQDFLBtvobzB-4M8l5l8QXKcUvqOiDgm8hyW1o6jU5kir035tS8VUYdpdlZ5idGZqEGAChS0pqSmh3tanhK5VVKTUjjNakgLETNKWCNxUXHZugKZHsupKcf5yhWc4bQmjbNHKK4LWmtMXPsDVJB8CDH32fsQ8YdBr2eFzrDBlHh8e8t-uYfb7BY9xB2Hk9YOPjVqdPSBm7mLDGYxlj0IPP0OMt9N76ALfn6NTpIcPFb5-j9_u7t-VjtXp5eFouVpWlpGOV1I4azjoneudEQ62lTHAtJddMCtZ3whgnLZWybQyjrXXW0I7bcq1Fp00zR_yoa1PMOYFTY_LF4F5Rog5pqY36S0sd0lKkgLHCXByZUOx9e0gqWw_Blg8S2J3qo_9X4wdN6Hux |
| Cites_doi | 10.1016/j.neuroscience.2013.11.049 10.1038/ncomms8934 10.1001/jamapsychiatry.2016.2902 |
| ContentType | Journal Article |
| Copyright | 2021 |
| Copyright_xml | – notice: 2021 |
| DBID | AAYXX CITATION |
| DOI | 10.1016/j.euroneuro.2021.01.022 |
| DatabaseName | CrossRef |
| DatabaseTitle | CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1873-7862 |
| EndPage | S12 |
| ExternalDocumentID | 10_1016_j_euroneuro_2021_01_022 S0924977X21000389 |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29G 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM 9JO AABNK AACTN AADFP AADPK AAEDT AAEDW AAGJA AAGUQ AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATCM AAXLA AAXUO ABBQC ABCQJ ABFNM ABFRF ABIVO ABJNI ABLVK ABMAC ABMZM ABOYX ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ACXNI ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AEVXI AFCTW AFKWA AFRHN AFTJW AFXIZ AFYLN AGHFR AGUBO AGWIK AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK AKRLJ ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDW HMK HMO HMQ HMT HVGLF HZ~ IHE J1W KOM LCYCR LX8 M29 M2V M34 M41 MO0 MOBAO N9A O-L O9- OAUVE OGGZJ OH0 OKEIE OU- OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SNS SPCBC SPT SSB SSH SSN SSP SSY SSZ T5K UNMZH WUQ XPP Z5R ~G- AAXKI AAYXX AFJKZ AKRWK CITATION |
| ID | FETCH-LOGICAL-c1062-9af1b726f8dff831cc1287a997a2982d68bbf9c19953b215cfcb167cdffa86ab3 |
| ISSN | 0924-977X |
| IngestDate | Thu Sep 26 23:25:53 EDT 2024 Fri Feb 23 02:43:56 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c1062-9af1b726f8dff831cc1287a997a2982d68bbf9c19953b215cfcb167cdffa86ab3 |
| ParticipantIDs | crossref_primary_10_1016_j_euroneuro_2021_01_022 elsevier_sciencedirect_doi_10_1016_j_euroneuro_2021_01_022 |
| PublicationCentury | 2000 |
| PublicationDate | March 2021 2021-03-00 |
| PublicationDateYYYYMMDD | 2021-03-01 |
| PublicationDate_xml | – month: 03 year: 2021 text: March 2021 |
| PublicationDecade | 2020 |
| PublicationTitle | European neuropsychopharmacology |
| PublicationYear | 2021 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Zugno, Chipindo, Volpato (bib0030) 2014; 259 Amminger, Schäfer, Schlögelhofer (bib0031) 2015; 6 Frajerman, Kebir, Chaumette (bib0029) 6 March 2020 McGorry, Nelson, Markulev (bib0032) 2017; 74 Zugno (10.1016/j.euroneuro.2021.01.022_bib0030) 2014; 259 Frajerman (10.1016/j.euroneuro.2021.01.022_bib0029) 2020 Amminger (10.1016/j.euroneuro.2021.01.022_bib0031) 2015; 6 McGorry (10.1016/j.euroneuro.2021.01.022_bib0032) 2017; 74 |
| References_xml | – volume: 6 start-page: 7934 year: 2015 ident: bib0031 article-title: Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study publication-title: Nat Commun contributor: fullname: Schlögelhofer – volume: 259 start-page: 223 year: 2014 end-page: 231 ident: bib0030 article-title: Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia publication-title: Neuroscience contributor: fullname: Volpato – year: 6 March 2020 ident: bib0029 article-title: Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets? publication-title: Encephale contributor: fullname: Chaumette – volume: 74 start-page: 19 year: 2017 end-page: 27 ident: bib0032 article-title: Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial publication-title: JAMA Psychiatry contributor: fullname: Markulev – volume: 259 start-page: 223 year: 2014 ident: 10.1016/j.euroneuro.2021.01.022_bib0030 article-title: Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia publication-title: Neuroscience doi: 10.1016/j.neuroscience.2013.11.049 contributor: fullname: Zugno – year: 2020 ident: 10.1016/j.euroneuro.2021.01.022_bib0029 article-title: Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets? publication-title: Encephale contributor: fullname: Frajerman – volume: 6 start-page: 7934 year: 2015 ident: 10.1016/j.euroneuro.2021.01.022_bib0031 article-title: Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study publication-title: Nat Commun doi: 10.1038/ncomms8934 contributor: fullname: Amminger – volume: 74 start-page: 19 year: 2017 ident: 10.1016/j.euroneuro.2021.01.022_bib0032 article-title: Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2016.2902 contributor: fullname: McGorry |
| SSID | ssj0015339 |
| Score | 2.3577573 |
| SourceID | crossref elsevier |
| SourceType | Aggregation Database Publisher |
| StartPage | S11 |
| Title | P.115 Membrane lipids in early phases of psychosis: potential biomarkers for a personalised medicine? |
| URI | https://dx.doi.org/10.1016/j.euroneuro.2021.01.022 |
| Volume | 44 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Bb9MwFLa6ceGCYIAYjMkHtAtLlbiOY--CGBTtAKiiRZq4RE7iaKlYGy3dYfx6nv0SJxuVACGkKmrdJLX8vr73-fnzCyGvRFiEJcxlgxi4R8CNNkGmwCAC2EgOAZPnTkRzNk8-n8v3Uz4djbonx_Rt_9XS0Aa2tjtn_8La_qbQAO_B5nAEq8Pxj-w-A_cUv_5kLmEaDATye1VXqHk1rpRxfQFhq_E653VTOU1cvd5Y2RDYy-7Ht5KdqwYFlrawMdL1BrhptxR_Vw_Y5fRdeUy8c90XxfZpe6DJSxsKsG7BeKAtABe5wSf1nfrmj_pS_6jcUr5s1cD-u4WV77abGMfD1AUbaLcwn_bLnhpMTDIeACs9xwiFblkmkyCRt_025wPHO29dtmk_sa3hATMVS1tTc-0GZGy7hXVbWR8RvU5xbjtj-8Iit4aqdsg9Bh7NOtRv8Re_XAWcGYs6tl2_JSTc-mPbadCA2iwekgftnIS-RTA9IiOz2iNHM7TfzTFd9Hv0mmN6RGcDyz4mxiGOdoijiDharahDHEXE0XVJPeJOqMcb7fFGAW9U0yHeaIe3N0_I1w_TxbuzoH14R5BHoWCB0mWUJUyUsihLOYnyHJhQopVKNFOSFUJmWQnuQKl4kgHvzMs8i0SSw9laCp1NnpLdFYzbM0Jjo4qCczhfKB4ro6WBeX2ihYmyqOBin4TdWKY11mhJO_HiMvXDn9rhT0N4MbZPTroxT1uqiRQyBaj87uLn_3LxC3K__ysckN3N1bV5SXaa4vrQYeonOlym7w |
| link.rule.ids | 315,782,786,27933,27934 |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=P.115+Membrane+lipids+in+early+phases+of+psychosis%3A+potential+biomarkers+for+a+personalised+medicine%3F&rft.jtitle=European+neuropsychopharmacology&rft.au=Frajerman%2C+A.&rft.au=Chaumette%2C+B.&rft.au=Lamazi%C3%A8re%2C+A.&rft.au=Tessier%2C+C.&rft.date=2021-03-01&rft.pub=Elsevier+B.V&rft.issn=0924-977X&rft.eissn=1873-7862&rft.volume=44&rft.spage=S11&rft.epage=S12&rft_id=info:doi/10.1016%2Fj.euroneuro.2021.01.022&rft.externalDocID=S0924977X21000389 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0924-977X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0924-977X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0924-977X&client=summon |